Document Detail

Long-term insulin pump treatment in girls with type 1 diabetes and eating disorders--is it feasible?
MedLine Citation:
PMID:  20879965     Owner:  NLM     Status:  In-Process    
AIM: This study evaluated the feasibility of insulin pump treatment in adolescent girls with type 1 diabetes mellitus (T1DM) and eating disorders (ED).
METHODS: Sixty-three girls >10 years old were included in the study. Forty-eight were treated with pump (no-ED-pump group); 15 had ED, of whom eight were treated with pump (ED-pump group), and seven were treated with multiple daily injections (MDI) (ED-MDI group).
RESULTS: Girls in the ED-pump group had higher hemoglobin A1c (HbA1c) compared to those in the no-ED-pump group both before and after pump initiation (P = 0.007). In the ED-pump group, levels 0-6 months after pump initiation were slightly but not significantly lower compared to baseline reference values (8.48% vs. 8.84%, respectively; P = 0.42). In the no-ED-pump group there was a significant decrease in HbA1c level 0-6 months after pump initiation (8.03% vs. 7.67%, respectively; P = 0.004). Thereafter HbA1c levels were not different from baseline reference on both groups. The rate of hypoglycemic episodes was similar in the ED pump and no-ED-pump groups (0.9 vs. 1.0 episodes per 100 patient-years, respectively). Prior to diagnosis of ED, mean HbA1c levels in the ED-pump group and the ED-MDI group were similar: 9.24 ± 1.25% versus 8.47 ± 1.30% (P = 0.51). In the time intervals after the diagnosis of ED, mean HbA1c level of all measurements in the eight girls in the ED-pump group was significantly lower compared with the seven patients in the ED-MDI group: 9.07 ± 1.33% versus 10.40 ± 2.01% (P = 0.04).
CONCLUSIONS: Treatment with an insulin pump was feasible in girls with T1DM and ED and resulted in significantly lower HbA1c levels compared to the ED-MDI group.
Orit Pinhas-Hamiel; Chana Graph-Barel; Valentina Boyko; Michal Tzadok; Liat Lerner-Geva; Brian Reichman
Related Documents :
12802265 - Euroscore overestimates the cardiac operative risk.
12558235 - Hemorrhage after coronary artery bypass graft procedures.
17938385 - Systematic review: the comparative effectiveness of percutaneous coronary interventions...
19635155 - Evaluation of preoperative intra-aortic balloon pump in coronary patients with severe l...
22648445 - Anterior colporrhaphy versus repair with mesh for anterior vaginal wall prolapse: a com...
8983555 - Absorbable skin graft staples: a clinical trial using graftac-x.
Publication Detail:
Type:  Journal Article     Date:  2010-09-30
Journal Detail:
Title:  Diabetes technology & therapeutics     Volume:  12     ISSN:  1557-8593     ISO Abbreviation:  Diabetes Technol. Ther.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100889084     Medline TA:  Diabetes Technol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  873-8     Citation Subset:  IM    
Maccabi Juvenile Diabetes Center, 4 Bar-Ilan Street, Raanana, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Health literacy, diabetes self-care, and glycemic control in adults with type 2 diabetes.
Next Document:  Automatic bolus and adaptive basal algorithm for the artificial pancreatic ?-cell.